9 drug(s) with this reaction
4,213 total reports
Sepsis has been reported as an adverse reaction across 9 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 4,213 adverse event reports mention sepsis in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with sepsis, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have sepsis listed in their FDA adverse event reports, sorted by report count:
In addition to sepsis, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
9 drug(s) manufactured by Amgen Inc have sepsis listed in their FDA adverse event reports: FILGRASTIM, DARBEPOETIN ALFA, PEGFILGRASTIM, EPOETIN ALFA, ROMIPLOSTIM, and others.
There are a combined 4,213 reports of sepsis across 9 Amgen Inc drug(s) in the FDA adverse event database.